Annals of Clinical Neurophysiology

The Korean Society of Clinical Neurophysiology (대한임상신경생리학회)
권호 표지
DOI QR코드

DOI QR Code

Relation of Bony Carotid Canal Diameter and Clinical Manifestations in Patients with Moyamoya Disease

모야모야병 환자의 뼈목동맥관 직경과 임상표현과의 관계

  • Ahn, So Hyun (Department of Neurology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University) ;
  • Song, Hong-ki (Department of Neurology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University) ;
  • Kim, Cheol Ho (Department of Neurology, Chuncheon Sacred Heart Hospital, College of Medicine) ;
  • Jang, Min Uk (Department of Neurology, Chuncheon Sacred Heart Hospital, College of Medicine) ;
  • Sohn, Jong-Hee (Department of Neurology, Chuncheon Sacred Heart Hospital, College of Medicine) ;
  • Choi, Hui Chul (Department of Neurology, Chuncheon Sacred Heart Hospital, College of Medicine)
  • 안소현 (한림대학교 강동성심병원 신경과) ;
  • 송홍기 (한림대학교 강동성심병원 신경과) ;
  • 김철호 (한림대학교 춘천성심병원 신경과) ;
  • 손종희 (한림대학교 춘천성심병원 신경과) ;
  • 장민욱 (한림대학교 춘천성심병원 신경과) ;
  • 최휘철 (한림대학교 춘천성심병원 신경과)
  • Received : 2016.02.28
  • Accepted : 2016.06.01
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Moyamoya disease is characterized by a progressive stenosis or occlusion of the intracranial internal carotid artery and/or the proximal portion of the anterior cerebral artery and middle cerebral artery. Whether the onset time was childhood or adulthood, the bony carotid canal diameter might be different, but reflects the size of internal carotid artery passing through the bony carotid canal. In this study, we aimed to identify the relationship between bony carotid canal diameter and clinical manifestation. Methods: 146 consecutive patients diagnosed with moyamoya disease by brain imaging studies were included. We measured the diameter of a transverse portion of bony carotid canal on bone window of a brain computed tomography(CT) image. Patients were divided into two groups, ischemic or hemorrhagic stroke according to clinical manifestation. As a result, 115 patients were included. The Suzuki stage was used as criteria for disease progression. Results: Bony carotid canal diameter was $3.6{\pm}0.5$ (right) and $3.6{\pm}0.4$ (left) in the hemorrhagic stroke group, and $3.7{\pm}0.4$ (right) and $3.6{\pm}0.4$ (left) in the ischemic stroke group. The bony carotid canal diameter of the moyamoya vessels (3.6 mm) was smaller than the diameter of non-moyamoya vessels (3.8 mm), significantly (p = 0.042). However, there was no difference in the collateral patterns and clinical manifestation in a comparison of both groups. Conclusions: In our study, there was no significant difference of clinical manifestations and collateral patterns depend on the bony carotid canal diameter in patients with moyamoya disease. These findings suggest that the clinical presentations of moyamoya disease are not related to the onset time of the disease.

Keywords

References

  1. Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 2015;8:49-68.
  2. Hertza J, Loughan A, Perna R, Davis AS, Segraves K, Tiberi NL. Moyamoya disease: a review of the literature. Appl Neuropsychol Adult 2014;21:21-27. https://doi.org/10.1080/09084282.2012.721147
  3. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008;79:900-904. https://doi.org/10.1136/jnnp.2007.130666
  4. Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, Choi JU, et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 2000;142:1263-1273. https://doi.org/10.1007/s007010070024
  5. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997;99 Suppl 2:S1-S5. https://doi.org/10.1016/S0303-8467(97)00031-0
  6. Motoshima S, Noguchi T, Kawashima M, Ooishi M, Irie H, Nishihara M, et al. Narrowed petrous carotid canal detection for the early diagnosis of moyamoya disease. Fukuoka Igaku Zasshi 2012;103:206-214.
  7. Watanabe A, Omata T, Koizumi H, Nakano S, Takeuchi N, Kinouchi H. Bony carotid canal hypoplasia in patients with moyamoya disease. J Neurosurg Pediatr 2010;5:591-594. https://doi.org/10.3171/2010.3.PEDS09417
  8. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997;99 Suppl 2:S238-S240.
  9. Hashimoto N, Tominaga T, Miyamoto S, Nagata I, Houkin K, Suzuki N, et al. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 2012;52:245-266. https://doi.org/10.2176/nmc.52.245
  10. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299. https://doi.org/10.1001/archneur.1969.00480090076012
  11. Liu W, Xu G, Liu X. Neuroimaging diagnosis and the collateral circulation in moyamoya disease. Interv Neurol 2013;1:77-86.
  12. Cali RL, Berg R, Rama K. Bilateral internal carotid artery agenesis: a case study and review of the literature. Surgery 1993;113:227-233.
  13. Handa J, Matsuda I, Nakasu S, Nakano Y. Agenesis of an internal carotid artery: angiographic, tomographic and computed tomographic correlation. Neuroradiology 1980;19:207-211. https://doi.org/10.1007/BF00376709
  14. Quint DJ, Silbergleit R, Young WC. Absence of the carotid canals at skull base CT. Radiology 1992;182:477-481. https://doi.org/10.1148/radiology.182.2.1732967
  15. Fujimura M, Mugikura S, Shimizu H, Tominaga T. Asymptomatic moyamoya disease subsequently manifesting as transient ischemic attack, intracerebral hemorrhage, and subarachnoid hemorrhage in a short period: case report. Neurol Med Chir (Tokyo) 2010;50:316-319. https://doi.org/10.2176/nmc.50.316
  16. He Y, Zhou Q, He M. An asymptomatic Moyamoya disease: autopsy case and literature review. Am J Forensic Med Pathol 2010;31:77-79. https://doi.org/10.1097/PAF.0b013e3181c215e2
  17. Ikeda K, Iwasaki Y, Kashihara H, Hosozawa K, Anan K, Tamura M, et al. Adult moyamoya disease in the asymptomatic Japanese population. J Clin Neurosci 2006;13:334-338. https://doi.org/10.1016/j.jocn.2005.02.026
  18. Jo KI, Yeon JY, Hong SC, Kim JS. Clinical course of asymptomatic adult moyamoya disease. Cerebrovasc Dis 2014;37:94-101. https://doi.org/10.1159/000356350
  19. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005;36:2148-2153. https://doi.org/10.1161/01.STR.0000182256.32489.99